Register Now: In Conversation with EBiSC2
Unlocking the Potential of Stem Cells: Discover the EBiSC Journey to Sustainability
Join the conversation on the initiative that’s shaping the future of biomedical research! On May 15, 2024, from 14:15 to 15:00 CEST (Europe/Brussels time), the Innovative Health Initiative (IHI) will host an interactive online event entitled “In conversation with… EBiSC2” (https://www.ihi.europa.eu/news-events/events/conversation-ebisc2). This live session is set to explore the journey of the EBiSC biobank to self-sustainability and the world of induced pluripotent stem cells (iPSCs), which are revolutionising the approach to understanding and treating complex diseases.
Why Should You Tune In?
The EBiSC2 project, initially launched under the Innovative Medicines Initiative, has made significant strides in establishing a globally operating, self-sustaining non-profit biobank and service provider for iPSCs. Having supported the EBiSC2 project with management, knowledge-sharing, marketing and stakeholder engagement for sustainability, we at ARTTIC Innovation are truly excited to see how smoothly EBiSC has transitioned from initial funding to a self-sustaining entity that continues to support the global research community.
EBiSC offers a renewable source of any cell type for research and therapeutic applications. iPSCs are mature adult cells, generated from tissues of people diagnosed with certain diseases, as well as healthy people. These stem cells have been reprogrammed to make them ‘pluripotent’, i.e. able to differentiate into any type of cell found in the human body, which can then be used by researchers to carry out experiments. iPSCs are invaluable for scientific studies. They allow researchers to delve into genetic diseases and develop new personalised treatments without the ethical concerns associated with embryonic stem cells.
The EBiSC collection contains over 900 iPSC lines from more than 30 different clinical studies representing diseases and conditions such as Parkinson’s disease, Alzheimer’s disease, Diabetes, Huntington’s disease, Dravet syndrome, Bardet-Biedl syndrome, depression and pain, eye diseases, heart disease and more. Via the open and searchable EBiSC catalogue (https://ebisc.org/search?q=), researchers can access a wide range of robust, high-quality iPSCs from diverse disease and genetic backgrounds as well as new derived products (https://ebisc.org/EBISC-NEUR1), along with their relevant datasets.
Archiving iPSCs in EBiSC creates a crucial legacy for researchers across the globe, allowing others to access these cells for their own studies. This enables continuity of research that can lead to medical breakthroughs that might otherwise have been interrupted by the discontinuation of funding. The upcoming event will explore how the EBiSC2 project has become a model of sustainability and continues to impact health research globally.
What to Expect
The 45-minute event promises to be an interactive platform, featuring a panel discussion followed by a Q&A session, allowing you to engage directly with leading scientists and innovators. The live event will be packed with insights from project coordinators and experts in stem cell research. They will discuss with you the project’s achievements, the power of public-private partnerships in health research and innovation, and the challenges they’ve overcome.
Who Should Attend?
This event is ideal for anyone interested in the latest developments in biomedical research such as disease modelling and early drug discovery, stem cell technology, and innovative health solutions. Whether you’re a researcher, clinician, student, or simply curious about the future of personalised drug development and healthcare, this webinar will provide you with a unique look into the cutting-edge of bioscience.
This event is not just about understanding a scientific project – it’s about exploring the promise of iPSCs and their potential to heal and cure. Join us to discover how synergistic initiatives like EBiSC are boosting a culture of openness and collaboration in the global scientific community and paving the way for future discoveries that are transforming medicine.
More about EBiSC at https://ebisc.org/.
POWERBASE facilitates green transition of emergency response organisations
POWERBASE project improves working conditions and facilitates the green transition of emergency response organisations.Twelve emergency response and research organisations have joined forces to prepare future procurement of renewable energy technologies to set the...
Senior Innovation Consultant (m/f/d)
We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for specialists with a passion for innovation, scientific writing and project management. This position is for experienced...
Junior Funding Consultant (m/f/d)
We offer you the unique opportunity to become part of a successful & young team in the attractive growth market for tax-incentivised research funding (R&D tax credits). We are looking for Junior Funding Consultants with a passion for innovation, scientific...
Junior Innovation Consultant (m/f/d)
We offer you the unique opportunity to become part of a dynamic team in the attractive field of innovation and research. We are looking for Innovation Consultants with a passion for innovation, scientific writing and project management. This position is for recent...
Why the carousel of amendments to the R&D tax credit law continues to turn
The R&D tax credits in 2024The year 2024 has proven to be decisive for the German R&D tax credits. Following the most recent amendment as part of the Growth Opportunities Act in March, the Federal Government realized during the budget consultations for 2025...
The R&D tax credit with a blind eye to earnings –
Why loss-making companies (wrongly) hesitate
Recapitulation The German R&D tax credit has become much more popular in recent years after a modest response following the introduction of the instrument. This can be seen not only in advertising and studies by various associations, but also in the bare figures...
First successful demonstration with 100% green H2
HYFLEXPOWER celebrates successful operation of a gas turbine with 100% green H2On October 12, 2023, at a public event hosted at the HYFLEXPOWER demonstrator site in Saillat-sur-Vienne, France, the HYFLEXPOWER consortium unveiled a ground-breaking achievement - the...
New Security Project AGILE Will Improve Disaster Risk Management
New international security project to improve disaster risk management for unexpected eventsThe international security project AGILE will kick start today. The project is to develop novel tools and methodologies for understanding, anticipating, and managing High...
How the government’s draft of the Growth Opportunities Act refines the research allowance
Government draft of the Growth Opportunities ActThe government draft of the submitted Growth Opportunities Act has once again undergone a significant redesign compared to the draft bill (§ 33 from p. 71). The revision regarding the Research Grants Act rewards small...
SYNERGISE for Improved Disaster Management
Internationally Funded Project to Develop an Integrated Toolkit for Improved Management of Natural and Man-Made Disasters Kicks-Off TodayTo boost the efficiency and safety of first responders during life-saving missions, the SYNERGISE team will develop a Novel...